PDBsum entry 4awj

Transcription

PDB id: 4awj

Contents

Protein chains

102 a.a.

87 a.a.

136 a.a.

87 a.a.

144 a.a.

86 a.a.

Ligands

ACT ×6

V6F ×4

ACY

GOL

Waters ×289

References listed in PDB file

Key reference

• Title: Dissecting fragment-Based lead discovery at the von hippel-Lindau protein:hypoxia inducible factor 1α protein-Protein interface.
• Authors: I.Van molle, A.Thomann, D.L.Buckley, E.C.So, S.Lang, C.M.Crews, A.Ciulli.
• Ref.: Chem Biol, 2012, 19, 1300-1312.
• PubMed id: 23102223

Abstract

Fragment screening is widely used to identify attractive starting points for drug design. However, its potential and limitations to assess the tractability of often challenging protein:protein interfaces have been underexplored. Here, we address this question by means of a systematic deconstruction of lead-like inhibitors of the pVHL:HIF-1α interaction into their component fragments. Using biophysical techniques commonly employed for screening, we could only detect binding of fragments that violate the Rule of Three, are more complex than those typically screened against classical druggable targets, and occupy two adjacent binding subsites at the interface rather than just one. Analyses based on ligand and group lipophilicity efficiency of anchored fragments were applied to dissect the individual subsites and probe for binding hot spots. The implications of our findings for targeting protein interfaces by fragment-based approaches are discussed.